These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 35136065)

  • 1. In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue.
    Silva-Pinheiro P; Nash PA; Van Haute L; Mutti CD; Turner K; Minczuk M
    Nat Commun; 2022 Feb; 13(1):750. PubMed ID: 35136065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.
    Mok BY; de Moraes MH; Zeng J; Bosch DE; Kotrys AV; Raguram A; Hsu F; Radey MC; Peterson SB; Mootha VK; Mougous JD; Liu DR
    Nature; 2020 Jul; 583(7817):631-637. PubMed ID: 32641830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo.
    Zekonyte U; Bacman SR; Smith J; Shoop W; Pereira CV; Tomberlin G; Stewart J; Jantz D; Moraes CT
    Nat Commun; 2021 May; 12(1):3210. PubMed ID: 34050192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases.
    Lee H; Lee S; Baek G; Kim A; Kang BC; Seo H; Kim JS
    Nat Commun; 2021 Feb; 12(1):1190. PubMed ID: 33608520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases.
    Lee S; Lee H; Baek G; Namgung E; Park JM; Kim S; Hong S; Kim JS
    Genome Biol; 2022 Oct; 23(1):211. PubMed ID: 36224582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs.
    Castillo SR; Simone BW; Clark KJ; Devaux P; Ekker SC
    Hum Gene Ther; 2024 Oct; 35(19-20):798-813. PubMed ID: 39212664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and prospects in mitochondrial genome editing.
    Phan HTL; Lee H; Kim K
    Exp Mol Med; 2023 May; 55(5):871-878. PubMed ID: 37121968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo.
    Gammage PA; Viscomi C; Simard ML; Costa ASH; Gaude E; Powell CA; Van Haute L; McCann BJ; Rebelo-Guiomar P; Cerutti R; Zhang L; Rebar EJ; Zeviani M; Frezza C; Stewart JB; Minczuk M
    Nat Med; 2018 Nov; 24(11):1691-1695. PubMed ID: 30250142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review.
    Gao Y; Guo L; Wang F; Wang Y; Li P; Zhang D
    Cytotherapy; 2024 Jan; 26(1):11-24. PubMed ID: 37930294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA.
    Mok BY; Kotrys AV; Raguram A; Huang TP; Mootha VK; Liu DR
    Nat Biotechnol; 2022 Sep; 40(9):1378-1387. PubMed ID: 35379961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in mitochondrial DNA base editing technology.
    Song RJ; Han L; Sun HF; Shen B
    Yi Chuan; 2023 Aug; 45(8):632-642. PubMed ID: 37609815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of mitochondrial genome engineering.
    Silva-Pinheiro P; Minczuk M
    Nat Rev Genet; 2022 Apr; 23(4):199-214. PubMed ID: 34857922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced C-To-T and A-To-G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED.
    Wei Y; Jin M; Huang S; Yao F; Ren N; Xu K; Li S; Gao P; Zhou Y; Chen Y; Yang H; Li W; Xu C; Zhang M; Wang X
    Adv Sci (Weinh); 2024 Jan; 11(3):e2304113. PubMed ID: 37984866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors.
    Lee S; Lee H; Baek G; Kim JS
    Nat Biotechnol; 2023 Mar; 41(3):378-386. PubMed ID: 36229610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Base Editing: Recent Advances towards Therapeutic Opportunities.
    Kar B; Castillo SR; Sabharwal A; Clark KJ; Ekker SC
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.
    Tolle I; Tiranti V; Prigione A
    EMBO Rep; 2023 Apr; 24(4):e55678. PubMed ID: 36876467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaining Insight into Mitochondrial Genetic Variation and Downstream Pathophysiology: What Can i(PSCs) Do?
    Moreira JD; Gopal DM; Kotton DN; Fetterman JL
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New potentials of mitochondrial DNA editing.
    Wang W; Wang X
    Cell Biol Toxicol; 2020 Oct; 36(5):391-393. PubMed ID: 32734362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering.
    Eghbalsaied S; Lawler C; Petersen B; Hajiyev RA; Bischoff SR; Frankenberg S
    Gene Ther; 2024 May; 31(5-6):209-223. PubMed ID: 38177342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility.
    Guo J; Yu W; Li M; Chen H; Liu J; Xue X; Lin J; Huang S; Shu W; Huang X; Liu Z; Wang S; Qiao Y
    Mol Cell; 2023 May; 83(10):1710-1724.e7. PubMed ID: 37141888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.